Rapid Micro Biosystems creates innovative products for fast, accurate, and efficient detection of microbial contamination in the manufacture of pharmaceuticals, biologics, biotechnology products, medical devices, and personal care products.
The company’s Growth Direct™—the first and only growth-based system to automate compendial testing—detects contamination more quickly, delivering compelling economic benefits to manufacturers while improving their quality control (QC) process.
Growth Direct addresses all key microbial QC applications and fits with current regulatory practices, a critical accelerator for adoption. Automated, accelerated analysis eliminates error-prone manual steps and saves labor. Rapid detection of contamination enables manufacturers to reduce inventory carrying costs, shorten manufacturing cycles, and reduce product losses, delivering significant cost savings and increased operational efficiency.
Rapid Micro Biosystems' proprietary technology, based on the detection of natural autofluorescence, was developed by the company's founder, Dr. Don Straus, PhD. The inventors of the core principle, “efficient blue light-emitting diodes, which has enabled bright and energy-saving white light sources,” won the Nobel Prize in Physics.
Rapid Micro Biosystems is headquartered in Lowell, Massachusetts, with operations in Lowell and Freising, Germany.